-
Mashup Score: 4BXCL701 Plus Pembrolizumab is Safe and Generates Early Antitumor Activity in Advanced PDAC - 6 day(s) ago
Benjamin A. Weinberg, MD, FACP, discusses the potential role of BXCL701 plus pembrolizumab in advanced pancreatic ductal adenocarcinoma.
Source: www.onclive.comCategories: General Medicine NewsTweet
-
Mashup Score: 2Domvanalimab Plus Zimberelimab and Chemo Set for Phase 3 Study After Showing Efficacy in Untreated Upper GI Cancers - 25 day(s) ago
STAR-221 will evaluate domvanalimab plus zimberelimab and chemotherapy for the first-line treatment of patients with gastric, GEJ, or esophageal adenocarcinoma.
Source: www.onclive.comCategories: General Medicine NewsTweet-
Domvanalimab Plus Zimberelimab and Chemo Set for Phase 3 Study After Showing Efficacy in Untreated Upper GI Cancers #oncology #gicsm @KlempnerSam @harvardmed @UCLAHealth https://t.co/KpsiQXYFeh
-
-
Mashup Score: 2FDA Grants Orphan Drug Designation to ADRX-0405 for Gastric Cancer - 1 month(s) ago
ADRX-0405 has received orphan drug designation from the FDA for the treatment of patients with gastric cancer.
Source: www.onclive.comCategories: General Medicine NewsTweet-
FDA Grants Orphan Drug Designation to ADRX-0405 for Gastric Cancer #oncology #GIcsm https://t.co/j8GCVWJ4nQ
-
BXCL701 Plus Pembrolizumab is Safe and Generates Early Antitumor Activity in Advanced PDAC. @benweinbergmd @LombardiCancer #oncology #GIcsm https://t.co/cDgbMkvirx